Technical Analysis for XTLB - XTL Biopharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade B 2.38 0.00% 0.00
XTLB closed unchanged on Monday, May 13, 2019, on 18 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical XTLB trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze Ended Range Expansion 0.00%
Gapped Up Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.03%
Bollinger Band Squeeze Range Contraction 3.03%

Older signals for XTLB ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of clinical unmet needs. It is focused on late stage clinical development of drugs for the treatment of multiple myeloma, schizophrenia, and hepatitis C. The company's lead drug candidate is recombinant human erythropoietin (rHuEPO) for the treatment of multiple myeloma blood cancer, as well as for the treatment of severe anemia. The rHuEPO has also granted an orphan drug designation from the FDA for the treatment of multiple myeloma blood cancer. The company is also developing SAM-101, a proprietary combination of antipsychotic drugs and a medicinal compound, which has completed Phase IIa clinical trials as a therapy for psychotic diseases, with focus on schizophrenia. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Herzliya, Israel.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Natural Sciences Medication Pharmacy Pharmaceutical Products Schizophrenia Multiple Myeloma FDA Hepatitis C
Is XTLB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.94
52 Week Low 1.43
Average Volume 2,205
200-Day Moving Average 2.1699
50-Day Moving Average 2.3388
20-Day Moving Average 2.3185
10-Day Moving Average 2.317
Average True Range 0.1096
ADX 8.36
+DI 43.6896
-DI 27.8517
Chandelier Exit (Long, 3 ATRs ) 2.3512
Chandelier Exit (Short, 3 ATRs ) 2.4788
Upper Bollinger Band 2.4874
Lower Bollinger Band 2.1496
Percent B (%b) 0.68
BandWidth 14.569765
MACD Line 0.006
MACD Signal Line -0.0003
MACD Histogram 0.0064
Fundamentals Value
Market Cap 12.29 Million
Num Shares 5.16 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -2.16
Price-to-Sales 0.00
Price-to-Book 5.40
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.53
Resistance 3 (R3) 2.55 2.51 2.51
Resistance 2 (R2) 2.51 2.48 2.51 2.50
Resistance 1 (R1) 2.45 2.45 2.43 2.43 2.49
Pivot Point 2.41 2.41 2.41 2.41 2.41
Support 1 (S1) 2.35 2.38 2.33 2.33 2.27
Support 2 (S2) 2.31 2.35 2.31 2.26
Support 3 (S3) 2.25 2.31 2.26
Support 4 (S4) 2.23